Skip to main content
. 2021 Nov 13;10(22):5278. doi: 10.3390/jcm10225278

Table 3.

Analysis of cardiac magnetic resonance findings.

Overall Population (n = 360) IPTW Population (n = 718)
High Serum Lactate Low Serum Lactate p Value High Serum Lactate Low Serum Lactate p Value
(n = 119) (n = 241) (n = 358) (n = 360)
Myocardial infarct size (%, of LV) 22.0 ± 11.4 18.9 ± 10.5 0.011 21.5 ± 11.1 19.2 ± 10.4 0.044
Area at risk (%, of LV) 37.4 ± 17.7 32.1 ± 15.1 0.003 37.0 ± 17.2 32.7 ± 15.0 0.013
Myocardial salvage index 41.1 ± 16.6 41.6 ± 16.8 0.780 41.5 ± 16.8 41.8 ± 16.8 0.865
MVO area (%, of LV) 3.9 ± 5.7 3.6 ± 5.4 0.597 3.7 ± 5.5 3.6 ± 5.4 0.680
Hemorrhagic infarction 53 (44.9) 96 (39.8) 0.359 166 (46.3) 143 (39.8) 0.194
LV end diastolic volume (mL) 149.4 ± 42.3 151.7 ± 40.9 0.623 151.2 ± 40.2 150.8 ± 41.2 0.915
LV end systolic volume (mL) 77.6 ± 39.6 75.1 ± 36.8 0.557 77.0 ± 36.1 75.3 ± 36.9 0.663
LV ejection fraction (%) 50.1 ± 11.8 52.3 ± 11.2 0.090 50.7 ± 11.0 51.8 ± 11.3 0.354
LV stroke volume (mL) 71.8 ± 17.3 76.6 ± 16.7 0.011 74.2 ± 17.7 75.5 ± 16.8 0.489
LV cardiac output (L/min) 5.1 ± 1.1 5.2 ± 1.1 0.669 5.2 ± 1.1 5.1 ± 1.1 0.573

Data are presented as n (%) or mean ± standard deviation. IPTW = Inverse probability of treatment weighting, LV = left ventricle (ventricular), MVO = microvascular obstruction.